Dear Contractor,

You will be aware that Community Pharmacy is in an unprecedented financial crisis.

Over recent weeks and months, CPNI has been in intensive discussions with the Health Minister and elected representatives to outline the financial challenges being faced by our sector – and the implications for patients and pharmacy services.

We are aware of the extremely difficult financial challenges of managing payments to wholesale suppliers. We know that there are increasing occasions when medicines cannot be supplied because cash flow is so restricted that payment to wholesalers cannot be made. We understand the frustration and despondency this is causing in the sector, and we know how diligently pharmacy contractors are working to look after the needs of their local community patients and customers.

Political Lobbying Campaign

We have met with the Health Minister and with the Permanent Secretary of the Department of Health on a number of occasions, and we have very recently briefed the Health Committee, and continue to engage with elected representatives. Many pharmacy contractors have independently written to the Minister, Health Committee members and civil servants to share their personal stories and to make a direct appeal for change. This has been a very important element of the lobbying campaign.

Changes we are calling for:

  • Urgent stabilisation of community pharmacy funding in the short-term and a re-set of community pharmacy funding.
  • Putting in place a Northern Ireland specific Drug Tariff that reflects Northern Ireland’s unique circumstances and that will assure sustainable service provision and medicine supply to patients going forward.
  • Investment in the community pharmacy network to further extend the range of community pharmacy services, so that we can continue to play a transformative role in helping to keep patients closer to home, for longer, and reducing pressures on general practice, out-of-hours, and secondary care.

Public Awareness Campaign

We are now putting this campaign in front of community pharmacy patients to explain why the current financial pressures mean that medicine supplies and pharmacy services cannot be guaranteed.

We rely on patients’ support, and we are asking for their understanding while this crisis is resolved.  We want patients to know that their local community pharmacy is doing its best and that this problem is affecting the whole community pharmacy sector in Northern Ireland.

In sharing this with patients, we are also seeking their support for our campaign. Pharmacies will receive campaign resource packs with information and materials which we hope will help you to create awareness and provide ways that patients and customers can give their support.

Campaign resource packs will contain:

  • Posters for your window and in-store.
  • Petition sheets for the counter.  These simply require the patient or customer’s name, postcode and a signature – no further address or contact details are required. Please encourage patients and customers to sign the petition.
  • A bundle of small flyers outlining the campaign and urging individuals to contact their local elected representatives.  These feature a QR code which can be scanned with a smartphone camera, to link to a page where they will find the contact details for their local politician.  The flyer will also provide suggested text for their correspondence.

This campaign will also be supported by social media assets which will be shared with you directly.

There is widespread political support for the role of community pharmacy services and it is important that the public voice is loud and clear when the 2024-25 Northern Ireland budget is being allocated in the coming weeks.

Campaign resource packs will be arriving by post over the course of this week.

I would encourage you to make pharmacists and the wider pharmacy team aware of the campaign and the important impact patients and customers can make in supporting it.

If you have any questions, please contact Jude Austin – judea@communitypharmacyni.co.uk

Yours sincerely,

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor
SPPG have issued correspondence relating to the COVID-19 Spring Booster Vaccination Service 8th April 2024.

SUMMARY

SPPG have issued a reminder to contractors who intend on providing the Spring COVID-19 vaccination programme to Care Homes to complete the online pairing survey by 15th April 2024.

ACTION

  • Contractors are asked to read the correspondence issued by SPPG 8th April 2024 regarding Care Home pairings for the Spring vaccination programme.
  • Those pharmacies that intend on vaccinating Care Homes are asked to complete the online pairing survey by 15th April 2024.
  • Each contracted pharmacy should select all care home(s) for which they will be paired with.

Any queries regarding the Community Pharmacy Vaccination Service should be directed to Greg Miller  (Greg.Miller@hscni.net) or Grainne McMahon (Grainne.McMahon4@hscni.net).

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
This update contains important information for community pharmacy teams.

CPNI ALERTS

DOH(NI) ALERTS

BSO ALERTS

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.
Or report medicine shortages, pricing and staffing issues via CPNI’s Medicine Shortage Reporter and Situation Reporter.
Please bring this to the attention of your pharmacy team(s).

Kind regards

SENT ON BEHALF OF
Gerard Greene
Chief Executive
Dear Colleague
It has been confirmed that the 3rd concessionary price update below that was granted on 28th March 2024 will be the final update for the month.


There will be no further concessionary prices to announce for the month of March.
DrugPack
Size
Concessionary Price
Amoxicillin 250mg/5ml oral suspension100£2.49
Aripiprazole 5mg tablets28£5.64
Benzylpenicillin 600mg powder for solution for injection
vials
2£6.01
Betahistine 16mg tablets84£7.78
Calcipotriol 0.005% / Betamethasone dipropionate 0.05%
ointment
30£11.58
Cefalexin 500mg capsules21£2.50
Cefalexin 500mg tablets21£2.39
Chlorphenamine 2mg/5ml oral solution sugar free150£3.24
Cinacalcet 30mg tablets28£9.58
Clarithromycin 500mg tablets14£6.26
Clobazam 10mg tablets30£4.71
Co-amoxiclav 500mg/125mg tablets21£3.54
Co-careldopa 25mg/100mg tablets100£9.02
Co-codamol 30mg/500mg capsules100£5.63
Codeine 15mg/5ml linctus200£2.75
Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops5£3.96
Duloxetine 30mg gastro-resistant capsules28£2.04
Estriol 1mg/g vaginal cream15£5.45
Etoricoxib 30mg tablets28£5.32
Famotidine 20mg tablets28£17.55
Famotidine 40mg tablets28£28.23
Glycopyrronium bromide 200micrograms/1ml solution for
injection ampoules
10£8.58
Hydrocortisone 1% cream15£2.36
Hydroxocobalamin 1mg/1ml solution for injection
ampoules
5£10.84
Ispaghula husk 3.5g effervescent granules sachets gluten
free sugar free
30£6.99
Ketoconazole 2% shampoo120£19.40
Lactulose 3.1-3.7g/5ml oral solution500£3.13
Latanoprost 50micrograms/ml / Timolol 5mg/ml eye drops2.5£7.48
Levothyroxine sodium 12.5microgram tablets28£17.57
Lofepramine 70mg tablets56£19.20
Mercaptopurine 50mg tablets25£8.62
Metoclopramide 10mg tablets28£1.09
Mometasone 0.1% cream30£3.88
Ondansetron 4mg tablets10£5.79
Pregabalin 300mg capsules56£3.08
Pregabalin 50mg capsules84£4.75
Prochlorperazine 3mg buccal tablets50£8.47
Promethazine hydrochloride 10mg tablets56£13.44
Propantheline bromide 15mg tablets112£100.61
Pyridostigmine bromide 60mg tablets200£19.33
Quetiapine 200mg tablets60£3.79
Quinine sulfate 200mg tablets28£7.65
Rasagiline 1mg tablets28£42.70
Rizatriptan 10mg tablets3£5.29
Sodium chloride 0.9% nebuliser liquid 2.5ml unit dose
ampoules
20£9.50
Sulpiride 200mg/5ml oral solution sugar free150£98.50
Tacrolimus 0.1% ointment30£15.59
Tacrolimus 0.1% ointment60£31.17
Tamsulosin 400microgram / Dutasteride 500microgram
capsules
30£14.83
Temazepam 10mg tablets28£24.75
Ursodeoxycholic acid 150mg tablets60£36.77
Zonisamide 100mg capsules56£20.28
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Shortage Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor
Correspondence has been issued by SPPG 4th April 2024 regarding Community Pharmacy Adherence Support.

SUMMARY

  • Since 1st May 2023 the Drug Tariff has been changed so that instalment dispensing is an exception facility for use only where the prescriber considers it essential to prevent abuse or misuse.
  • As public funding is being utilised to support community pharmacies in meeting their obligations under the Disability Discrimination Act 1995 (DDA), SPPG are requesting information on the number of patients currently being provided with adherence support.
  • Adherence support includes provision of a Monitored Dosage System (MDS), pill crushers, reminder charts/alarms, or dexterity aids.
  • All patients receiving adherence support should be included with the following exceptions:
    • Patients who reside in Care Homes whose medicines are provided via MDS.
    • Patients with an instalment endorsement to prevent misuse or abuse of their medicines i.e. dispensing in skillets for daily or weekly patients. Please note: where these patients receive a form of adherence support such as MDS, they should be included on your list. There are instances where a patient receives both instalment dispensing and adherence support.
    • Patients who do not require support as a reasonable adjustment under DDA but for whom the pharmacy still provide adherence support e.g. requested for convenience.
  • The quarterly adherence return which was previously required will now be stood down.
  • SPPG have requested this information to be submitted by Friday 19th April 2024 using the following link.

ACTION

  • Contractors are asked to review the correspondence issued by SPPG 4th April 2024 regarding Community Pharmacy Adherence Support and share with relevant team members.
  • SPPG are requesting information on the number of patients currently being provided with adherence support using the following link by Friday 19th April 2024. Please note the exceptions listed in the correspondence.
  • The quarterly adherence return will now be stood down and is no longer required.
  • Guidance is available which provides information to community pharmacies in relation to their statutory requirements under DDA

For any further information please contact CPNI offices.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Contractor
Correspondence has been issued by SPPG 4th April 2024 regarding the Living Well Campaign.

SUMMARY

  • The survey for the campaign ‘Know you Units’ opened on the 1stApril 2024 and can be accessed here
  • The Living Well summary reports for the campaigns ‘Live Longer and Stronger’, ‘Care in the Sun’, ‘Childhood Immunisation’, ‘Keep Antibiotics Working’ are now available and can be accessed here.
  • The current campaign ‘Cancer Screening Saves Lives’ began on 1st April 2024 and NICPLD are hosting a bespoke training  webinar on 9th April to help pharmacy teams identify individuals who are eligible for cancer screening.

ACTION

  • Contractors are asked to review the correspondence issued by SPPG 4th April 2024 regarding the Living Well Service and share with relevant team members.
  • The survey for the campaign ‘Know Your Units’ is now available and must be completed before 6pm 29th April 2024.
  • NICPLD are hosting a webinar on 9th April 2024 to help pharmacy teams identify individuals who are eligible for cancer screening as part of the current campaign ‘Cancer Screening Saves Lives’

For any further information please contact CPNI offices.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive